Breeze Meds vs Eden Health GLP-1: Which GLP-1 Provider Is Better?
A side-by-side comparison of Breeze Meds and Eden Health GLP-1 covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#31 of 31Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsEden Health GLP-1
#5 of 31Full-service telehealth platform with physician-led GLP-1 programs and thorough medical monitoring throughout your journey.
Visit Eden Health GLP-1| Feature | Breeze Meds | Eden Health GLP-1 |
|---|---|---|
| Our Score | 7.3/10 | 8.6/10 |
| Starting Price | $189/mo | $300/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Users wanting comprehensive medical oversight with their GLP-1 treatment |
| Ranking | #31 | #5 |
Pros & Cons Compared
Breeze Meds
Pros
- +Fast shipping
- +Simple enrollment
- +Competitive pricing
- +No fuss approach
Cons
- −Compounded only
- −Less comprehensive support
Eden Health GLP-1
Pros
- +Quarterly blood panels (metabolic, lipid, A1C) included in the monthly price
- +Board-certified obesity medicine physicians — not general practitioners or NPs
- +Structured titration protocol with mandatory check-ins before each dose increase
- +Can prescribe brand-name Wegovy, Zepbound, or compounded semaglutide/tirzepatide
Cons
- −At $300/mo, it's nearly 2x the cost of comparable platforms like Willow or Henry Meds
- −No insurance billing — the premium price is entirely out-of-pocket
Our Verdict
Eden Health GLP-1 edges out Breeze Meds with a score of 8.6/10 vs 7.3/10. If budget is your priority, Breeze Meds starts at $189/mo compared to Eden Health GLP-1's $300/mo. Eden Health GLP-1 offers both brand-name and compounded medications, giving you more flexibility. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Eden Health GLP-1 if you want: users wanting comprehensive medical oversight with their glp-1 treatment.